Ulipsu’s embedded skill education model has enabled over a million student projects across 350+ schools in India and abroad.
EMERALD-3: Phase III trial of IMFINZI ® (durvalumab) in combination with IMJUDO ® (tremelimumab-actl), with or without lenvatinib, and transarterial chemoembolization (TACE) in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results